CD4 and laryngeal carcinoma: Our recently published study revealed that EBV infection may affect the PD-1/PD-L1 pathway and the development of laryngeal cancer; moreover, the level of PD-1 on CD4+ T cells in lymph nodes may serve as a marker for laryngeal cancer treatment and prognosis [5].